HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $791,000 | +4.8% | 6,271 | 0.0% | 0.03% | +3.6% |
Q2 2019 | $755,000 | +37.5% | 6,271 | 0.0% | 0.03% | +27.3% |
Q1 2019 | $549,000 | -8.0% | 6,271 | +5.0% | 0.02% | -18.5% |
Q4 2018 | $597,000 | -12.7% | 5,971 | 0.0% | 0.03% | +8.0% |
Q3 2018 | $684,000 | +63.2% | 5,971 | +27.8% | 0.02% | +47.1% |
Q2 2018 | $419,000 | +22.5% | 4,671 | 0.0% | 0.02% | +21.4% |
Q1 2018 | $342,000 | +26.2% | 4,671 | 0.0% | 0.01% | +27.3% |
Q4 2017 | $271,000 | +52.2% | 4,671 | +17.6% | 0.01% | +37.5% |
Q3 2017 | $178,000 | +31.9% | 3,971 | +16.6% | 0.01% | +14.3% |
Q2 2017 | $135,000 | +75.3% | 3,407 | +79.3% | 0.01% | +75.0% |
Q1 2017 | $77,000 | +6.9% | 1,900 | +5.6% | 0.00% | 0.0% |
Q4 2016 | $72,000 | +10.8% | 1,800 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $65,000 | -94.9% | 1,800 | -93.6% | 0.00% | -80.0% |
Q2 2016 | $1,269,000 | +292.9% | 28,017 | +203.7% | 0.02% | +300.0% |
Q1 2016 | $323,000 | -18.6% | 9,225 | -25.0% | 0.01% | -16.7% |
Q4 2015 | $397,000 | +242.2% | 12,300 | +241.7% | 0.01% | +200.0% |
Q3 2015 | $116,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |